Physician profile
Mitchell Perry
NPI 1356819411
$2,408.31
in general payments reported to CMS, 2019-2025
16 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $612 · 2022: $384 · 2023: $321 · 2024: $575 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,412.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $654.18 | 2021-2025 | Na, Va-Lcp, Motoband |
| Stryker Corporation | $600.37 | 2021-2024 | Gamma, Blueprint Patient Specific Instrumentation |
| Smith+Nephew, INC. | $272.67 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, N/A, Lens 4k |
| Davol INC. | $246.62 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $158.04 | 2024 | Iovera, Exparel, Zilretta |
| Globus Medical, INC. | $119.57 | 2025 | Senza |
| Ferring Pharmaceuticals INC. | $88.45 | 2022-2024 | Euflexxa |
| Boston Scientific Corporation | $50.24 | 2023 | |
| Heron Therapeutics, INC. | $34.57 | 2024-2025 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $33.62 | 2024-2025 | |
| Nalu Medical, INC. | $33.07 | 2025 | Nalu Neurostimulation System |
| Dynasplint Systems INC. | $28.75 | 2025 | Dynasplint |
| Integra Lifesciences Corporation | $28.19 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Avanos Medical | $23.38 | 2024 | Trivisc Sodium Hyaluronate |
| Bioventus LLC | $22.00 | 2024 | Durolane |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.59 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.